Lipid-DNA Labeling for Single EV Quantitation via PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying extracellular vesicles (EVs) and other lipid bilayer particles are limited by sensitivity, as they rely on sparse RNA or DNA sequences, making it difficult to detect single EVs effectively.
Innovation Solution
The method involves labeling lipid bilayer particles with lipid-tagged single-stranded DNA (ssDNA) that can be amplified by PCR, allowing for the specific capture and quantification of particles displaying specific surface antigens using qPCR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current EV detection methods using immunocapture and endogenous RNA/DNA amplification are employed, then EV subpopulations can be quantified, but the sensitivity is insufficient to detect single EVs
Solution Approach 1:
The patent applies preliminary action by pre-labeling EVs with lipid-tagged ssDNA oligos before detection. The oligos are incorporated into the EV membrane in advance, ensuring that each EV carries multiple copies of the detection sequence. This pre-labeling step resolves the sparsity problem of endogenous nucleic acids by providing abundant, evenly distributed targets for amplification, enabling single EV detection.
Solution Approach 2:
The patent changes the fundamental parameter of what is being amplified. Instead of amplifying sparse endogenous RNA/DNA, the method amplifies exogenously introduced lipid-tagged ssDNA oligos that are uniformly distributed across EV surfaces. This parameter change from endogenous to exogenous nucleic acid targets dramatically increases the copy number per EV, resolving the sensitivity limitation.
2Measurement precision
If lipid-tagged ssDNA labeling is used to enable single EV detection, then detection sensitivity improves, but the method complexity increases
Solution Approach 1:
The patent uses lipid-tagged ssDNA oligos as an intermediary between the EV and the detection system. The lipid tag embeds into the EV membrane while the ssDNA portion provides a handle for capture and amplification. This intermediary resolves the complexity issue by providing a simple, universal labeling strategy that works for all EVs regardless of their native content, making the method broadly applicable yet highly sensitive.
Solution Approach 2:
The lipid-tagged ssDNA oligos serve multiple functions: they anchor to the EV membrane, provide capture handles for immunocapture or oligo-based enrichment, and serve as templates for qPCR amplification. This multi-functionality resolves method complexity by consolidating multiple requirements into a single labeling reagent, simplifying the overall workflow while achieving single EV detection.
3Ease of manufacture
If endogenous RNA or DNA sequences are used for quantification, then the method is simpler, but the quantification accuracy is limited due to sparse distribution
Solution Approach 1:
The patent uses copying by introducing multiple copies of a standardized ssDNA sequence onto each EV through lipid tagging. Instead of relying on the single or few copies of endogenous nucleic acids, each EV is equipped with numerous identical ssDNA copies that serve as amplification targets. This copying strategy maintains method simplicity while dramatically improving quantification accuracy through increased signal abundance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the ultra-sensitive detection and quantification of lipid bilayer particles, including single EVs, with a significant improvement in sensitivity compared to existing methods, facilitating applications in disease diagnosis, monitoring, and drug discovery.
Implementation Method 1
the lipids self-embed into the lipid bilayer membrane of the particles
Implementation Method 2
anchor sequences hybridize via complementary base pairing, preventing the anchor oligo from dissociating from the membrane; the adhesion sequences hybridize, capturing the detection oligo onto the particles
Implementation Method 3
employing a restriction enzyme to release the ssDNA label after the capture
Implementation Method 4
amplified by polymerase chain reaction (PCR) to quantify particles captured via specific antigen binding or complementary oligonucleotide hybridization
Data Source
AI summary
Lipid bilayer particles, such as extracellular vesicles (EVs), are labeled with lipid-tagged single-stranded DNA (ssDNA), which is amplified by polymerase chain reaction (PCR) to quantify particles captured via surface marker interactions or complementary oligonucleotide hybridization.